Delivery Order SPE2DB20D1047-SPE2DB24FF70J

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3111|SPE2DB24FA5YD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a ceiling value of $7,079.98 and a completion date of December 15, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB24FHR24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patches, with a total ceiling value of $5,807.40 and an ultimate completion date of June 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
This federal contract award, valued at $4,648.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a medical product used for pain management. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM1W3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, and has a ceiling value of $2,087.58. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 9, 2024. It is not designated as a...
This federal contract award, valued at $4,937.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a medical product used for pain management. The contract is a Firm Fixed Price Delivery Order, with a period of performance through June 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award, SPE2DB20D2104|SPE2DB24FV41R, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a medical product used for pain management. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,421.22 and a performance period through July 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The contract has a ceiling value of $2,317.44 and a completion date of February 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as AmerisourceBergen), valued at up to $999,999,999.00 through December 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The contract has a ceiling value of $1,301.58 and an ultimate completion date of September 27, 2021. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $8,053.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a medical product used for pain management. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $2,339.48. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB24FF70J
    Delivery Order

This federal contract award, with ID SPE2DB20D1047|SPE2DB24FF70J, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product used for pain management. The contract has a firm fixed price, with a ceiling value of $1,142.39, and an ultimate completion date of May 21, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This contract award was not designated with a set-aside requirement, indicating open competition. The contract supports the DLA's mission of providing essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/16/25, 11:43 AM